Paraneoplastic Glomerular Diseases.
Cancer
Membranous nephropathy
Paraneoplastic glomerular diseases
Podocytopathy
Thrombotic microangiopathy
Journal
Advances in kidney disease and health
ISSN: 2949-8139
Titre abrégé: Adv Kidney Dis Health
Pays: United States
ID NLM: 9918523075306676
Informations de publication
Date de publication:
Jul 2024
Jul 2024
Historique:
received:
01
02
2024
revised:
25
04
2024
accepted:
30
04
2024
medline:
1
8
2024
pubmed:
1
8
2024
entrez:
31
7
2024
Statut:
ppublish
Résumé
Paraneoplastic glomerular disease (PGD) develops from tumor cell products, leading to renal dysfunction. Unlike direct tumor effects, PGD illustrates the complex association between cancer and diverse clinical presentations and outcomes. Initially detected in a Hodgkin's disease patient, current research has defined diagnostic criteria based on PGD symptoms and cancer progression. PGDs, although rare (found in <1% of adult cancer patients with overt renal manifestations), are crucial, as they can signal cancer onset and frequently resist standard glomerulonephritis treatments. The emerging field of onconephrology studies this relationship between kidney disorders and cancers. The exact cause of many PGD cases remains unknown. This review examines PGDs, their clinicopathological features, related cancers, and mechanisms, emphasizing the need for early diagnosis and tailored treatment for kidney disease and linked cancer.
Identifiants
pubmed: 39084760
pii: S2949-8139(24)00082-X
doi: 10.1053/j.akdh.2024.04.008
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
346-357Informations de copyright
Copyright © 2024 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.